Proteome Sciences, a global leader in applied proteomics, uses high sensitivity proprietary technologies to detect protein biomarkers and target proteins for specific diseases/indication areas. The biomarkers discovered in body fluids (i.e. serum) or tissues (liver) are validated, developed and commercialized as diagnostic, prognostic or therapeutic products through strategic alliances and out-licensing. In addition to considerable expertise across the generic technologies which make up proteomics, Proteome Sciences has built up a range of proprietary techniques including PST®, qPST™ and TMT® for gel-free proteomic analysis. Through its unique ProteoSHOP® toolkit, Proteome Sciences provides high sensitivity/high throughput proteomics solutions, including traditional two dimensional gel-based electrophoresis (2DE) and proprietary gel-free protein sequence tag technologies (PST®, qPST™& TMT®).

Core competencies:
  • Proteomics research
  • Identification of protein biomarkers and target proteins